以岭药业跌2.02%，成交额7759.54万元，主力资金净流出619.48万元

Core Viewpoint - Yiling Pharmaceutical's stock price has shown fluctuations, with a recent decline of 2.02% and a year-to-date increase of 5.27%, indicating mixed market sentiment towards the company [1]. Group 1: Stock Performance - As of January 29, Yiling Pharmaceutical's stock price was 17.97 yuan per share, with a market capitalization of 30.023 billion yuan [1]. - The stock has experienced a 1.96% decline over the last five trading days, but a 5.09% increase over the last 20 days [1]. - The company has seen a net outflow of 619.48 million yuan in principal funds, with significant selling pressure from large orders [1]. Group 2: Financial Performance - For the period from January to September 2025, Yiling Pharmaceutical reported a revenue of 5.868 billion yuan, a year-on-year decrease of 7.82%, while the net profit attributable to shareholders was 1 billion yuan, reflecting an 80.33% increase year-on-year [2]. - Cumulatively, the company has distributed 4.455 billion yuan in dividends since its A-share listing, with 1.838 billion yuan distributed over the past three years [3]. Group 3: Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 10.22% to 152,700, while the average number of circulating shares per person increased by 11.38% to 9,013 shares [2]. - The top circulating shareholder, Hong Kong Central Clearing Limited, increased its holdings by 8.1119 million shares, while Southern CSI 500 ETF reduced its holdings by 256,900 shares [3].